Trials / Withdrawn
WithdrawnNCT04384679
Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery
The Evaluation of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Weill Medical College of Cornell University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of topical hemostatic powder containing hydrophilic polymer with potassium ferrate for bleeding control after nail surgical procedures
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hydrophilic polymer and potassium ferrate powder | Application with pressure until hemostasis is achieved |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2022-12-01
- Completion
- 2023-12-01
- First posted
- 2020-05-12
- Last updated
- 2022-08-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04384679. Inclusion in this directory is not an endorsement.